on contacts the skin or mucosa, immediately wash the skin thoroughly with soap and water or rinse the mucosa with copious amounts of water. Several guidelines on this subject have been published.1-7 There is no general agreement that all of the procedures recommended in the guidelines are necessary or appropriate.
REFERENCES
Recommendations for the Safe Handling of Parenteral Antineoplastic Drugs. NIH Publication No. 83-2621. For sale by the Superintendent of Documents, U.S. Government Printing Office, Washington, DC 20402.
AMA Council Report. Guidelines for Handling Parenteral Antineoplastics. JAMA 1985; 253 (11):1590-1592.
National Study Commission on Cytotoxic Exposure–Recommendations for Handling Cytotoxic Agents. Available from Louis P. Jeffrey, Sc.D., Chairman, National Study Commission on Cytotoxic Exposure, Massachusetts College of Pharmacy and Allied Health Sciences, 179 Longwood Avenue, Boston, Massachusetts 02115.
Clinical Oncological Society of Australia: Guidelines and Recommendations for Safe Handling of Antineoplastic Agents. Med J Australia 1983; 1:426-428.
Jones, RB, et al: Safe Handling of Chemotherapeutic Agents: A Report from the Mount Sinai Medical Center. CA–A Cancer Journal for Clinicians 1983; (Sept./Oct.)258-263.
American Society of Hospital Pharmacists Technical Assistance Bulletin on Handling Cytotoxic and Hazardous Drugs. Am J Hosp Pharm 1990; 47:1033-1049.
Controlling Occupational Exposure to Hazardous Drugs. (OSHA WORK-PRACTICE GUIDELINES). Am J Health-Syst Pharm 1996; 53:1669-1685.
Manufactured by:
Baxter Healthcare Corporation
Deerfield, IL 60015 USA
For Product Inquiry 1800 ANA DRUG (1-800-262-3784)
Made in Germany
Rev Nov 2008
Baxter and Ifex are trademarks of Baxter International Inc.
HA-30-01-048
PACKAGE LABEL.PRINCIPLE DISPLAY PANEL
IFEX Container Label
NDC 0338-3991-01
IFEX
IFOSFAMIDE FOR INJECTION, USP
Rx only
1 g
SINGLE-DOSE VIAL
This vial contains 1g ifosfamide.
Add 20 mL Sterile Water for
Injection, USP, or Sterile
Bacteriostatic Water for Injection,
USP, (benzyl alcohol or parabens
preserved), shaking to dissolve,
for a reconstituted concentration
of 50 mg per mL.
Store at controlled room
temperature 20° C to 25° C
(68° F to 77° F)
Protect from temperatures
above 30° C (86° F).
FOR IV USE
READ ACCOMPANYING
PACKAGE INSERT for detailed
indications, dosage, and
precautions.
Manufactured by:
Baxter Healthcare Corporation
Deerfield, IL 60015 USA
USA 5561 0780 C 85
IFEX Carton Label
1 vial
NDC 0338-3991-01
IFEX
(ifosfamide for injection, USP)
Single-Dose Vial
FOR IV USE
Rx only
1 g
Baxter
Manufactured by
Baxter Healthcare Corporation
Deerfield, IL 60015 USA
This vial contains 1 g ifosfamide. Add
20 mL Sterile Water for Injection, USP,
or Sterile Bacteriostatic Water for
Injection, USP, (benzyl alcohol or
parabens preserved), shaking to
dissolve, for a reconstituted
concentration of 50 mg per mL.
READ ACCOMPANYING PACKAGE
INSERT for detailed indications,
dosage, and precautions.
Store at controlled room
temperature 20° C to 25° C
(68° F to 77° F). Protect from
temperatures above 30° C (86° F).
Constituted solutions should be
refrigerated and used within 24 hours.
Manufactured by:
Baxter Healthcare Corporation
Deerfield, IL |